Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Back
Favorite
Facebook
Tweet
Print
A PHASE I/II CLINICAL TRIAL OF NRTX-1001 INHIBITORY INTERNEURON CELL THERAPY FOR DRUG-REFRACTORY FOCAL EPILEPSY
Saturday, July 13, 2024
10:05 AM – 10:25 AM
CEST
Location: Hall 1, Level 2
Plenary Speaker(s)
Catherine Priest, PhD (she/her/hers)
Neurona Therapeutics, USA
